Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Oncimmune patents

List of Oncimmune patents

List of Genelux Corporation patents

List of Neogenomics patents

List of Translational Drug Development (Td2) patents

List of founders from Poland

Psychotherapy venture capital investors

Patents where

Current Assignee

Name

is

Oncimmune

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11609237 Marker sequences for diagnosing and stratifying systemic sclerosis patients	Patent 11609237 was granted and assigned to Oncimmune on March, 2023 by the United States Patent and Trademark Office.	Oncimmune	Oncimmune		United States Patent and Trademark Office	11609237	March 21, 2023
	‌ US Patent 8927223 Immunoassay methods	Patent 8927223 was granted and assigned to Oncimmune on January, 2015 by the United States Patent and Trademark Office.	Oncimmune	Oncimmune		United States Patent and Trademark Office	8927223	January 6, 2015
	‌ US Patent 9719984 Immunoassay methods	Patent 9719984 was granted and assigned to Oncimmune on August, 2017 by the United States Patent and Trademark Office.	Oncimmune	Oncimmune		United States Patent and Trademark Office	9719984	August 1, 2017
	‌ US Patent 8722339 Immunoassay methods	Patent 8722339 was granted and assigned to Oncimmune on May, 2014 by the United States Patent and Trademark Office.		Oncimmune		United States Patent and Trademark Office	8722339	May 13, 2014
	‌ US Patent 8114604 Tumour markers	Patent 8114604 was granted and assigned to Oncimmune on February, 2012 by the United States Patent and Trademark Office.		Oncimmune		United States Patent and Trademark Office	8114604	February 14, 2012
	‌ US Patent 9714938 Immunoassay methods	Patent 9714938 was granted and assigned to Oncimmune on July, 2017 by the United States Patent and Trademark Office.	Oncimmune	Oncimmune		United States Patent and Trademark Office	9714938	July 25, 2017
	‌ US Patent 9696319 Tumour markers	Patent 9696319 was granted and assigned to Oncimmune on July, 2017 by the United States Patent and Trademark Office.		Oncimmune		United States Patent and Trademark Office	9696319	July 4, 2017
	‌ US Patent 8574848 Immunoassay methods			Oncimmune		United States Patent and Trademark Office	8574848	November 5, 2013

8 results

0 selected

8 results

0 selected